Cannabidiol (CBD) is a cannabis substance that has considerable medical benefits, however it does not make people feel "stoned" and can actually counteract the psychoactivity of THC. The fact that CBD rich cannabis is non-psychoactive or less psychedelic than THC-dominant versions makes it an enticing option for patients searching for remedies for inflammation, chronic pain, anxiety, seizures, and other conditions without the potentially unwanted high sensation.
Scientific research studies (much of it sponsored by the United States federal government) validates CBD's prospective as a treatment for a large range of conditions, including arthritis, diabetes, alcohol addiction, MS, chronic discomfort, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has verifiable neuroprotective and neurogenic effects, and its anti cancer benefits are currently being examined at several academic establishments. Additional studies show that CBD is safe even at very high doses.
Practically everyone wants to know where to get CBD rich products and the best ways to use them to their full potential. After decades in which only high THC cannabis was available in North America and abroad, CBD rich products are now being offered to medical users.
" CBD-rich" versus "CBD dominant:" By "CBD-rich," we mean a cannabis product that has equal quantities of CBD and THC, or more CBD than THC (usually a minimum of 4 percent CBD by dry weight.). By "CBD-dominant," we imply products CBD-rich, however they have little THC.
THE RE-EMERGENCE OF CBD: A BRIEF HISTORY
In the spring of 1998, the British government accredited a business called GW Pharmaceuticals to grow cannabis and establish a precise and constant extract for use in medical trials. GW's co-founder Geoffrey Guy, MD, was convinced that using CBD-rich plants, GW might produce a cannabis based medication with little or no psychoactive results.
That summer he described his technique at a conference of the International Cannabinoid Research Study Society (ICRS). In addition to countering the psychoactivity of THC, Guy stated, CBD gave advantages of its own. GW got its CBD-rich plant by acquiring what they needed from HortaPharm, a Dutch seed business run by American expatriate gardeners, David Watson and Robert Clarke.
Animal research studies had long suggested that CBD lessens anxiety and minimizes the intensity and frequency of seizures. Generations of breeding cannabis for higher THC and a strong "high" had actually decreased the CBD to trace amounts in many cannabis varieties in Northern California, America's cannabis hub at the time.
As the years passed, increasingly more promising scientific studies regarding CBD were explained at conferences of the ICRS. In the fall of 2009, Oakland's Steep Hill Lab checked cannabis samples supplied by Harborside Health Center and discovered a couple of variants with more CBD than THC. It was very unexpected.
Soon, a number of labs in medical cannabis states were calibrating cannabinoid ratios and identifying the unique CBD rich plants. Eventually a handful of CBD-dominant plant variants with 20-to-1 CBD : THC ratios or higher were found, fostering an industry of CBD rich oil extracts and other CBD-rich products.
Fast forward to today and you'll find the CBD industry thriving, with year after year growth and with no signs of slowing down. CBD is now legal in all 50 states and many other countries are relaxing their laws and regulations in regards to CBD since it has been proven to help with a wide variety of illnesses and diseases. CBD oils future is bright as a natural wellness aid. It will be exiting to see where the industry foes in the next 5-10 years.